These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 16447775

  • 1. [Perspective for the treatment of diabetic neuropathy: translation from molecular studies to bedside].
    Yagihashi S, Yamagishi S, Wada R.
    Rinsho Shinkeigaku; 2005 Nov; 45(11):966-8. PubMed ID: 16447775
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. C-peptide, Na+,K(+)-ATPase, and diabetes.
    Vague P, Coste TC, Jannot MF, Raccah D, Tsimaratos M.
    Exp Diabesity Res; 2004 Nov; 5(1):37-50. PubMed ID: 15198370
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pathological mechanisms involved in diabetic neuropathy: can we slow the process?
    Sima AA.
    Curr Opin Investig Drugs; 2006 Apr; 7(4):324-37. PubMed ID: 16625819
    [Abstract] [Full Text] [Related]

  • 8. Role of advanced glycation end products and their receptors in development of diabetic neuropathy.
    Wada R, Yagihashi S.
    Ann N Y Acad Sci; 2005 Jun; 1043():598-604. PubMed ID: 16037282
    [Abstract] [Full Text] [Related]

  • 9. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis.
    Leonelli E, Bianchi R, Cavaletti G, Caruso D, Crippa D, Garcia-Segura LM, Lauria G, Magnaghi V, Roglio I, Melcangi RC.
    Neuroscience; 2007 Feb 23; 144(4):1293-304. PubMed ID: 17187935
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Can diabetic neuropathy be prevented?
    Park TS, Park JH, Baek HS.
    Diabetes Res Clin Pract; 2004 Dec 23; 66 Suppl 1():S53-6. PubMed ID: 15563981
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Role of neuropoietic cytokines in development and progression of diabetic polyneuropathy: from glucose metabolism to neurodegeneration.
    Skundric DS, Lisak RP.
    Exp Diabesity Res; 2003 Dec 23; 4(4):303-12. PubMed ID: 14668051
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Disorders of sorbitol and myoinositol metabolism and the activity of sodium, potassium ATPase in the pathogenesis of peripheral neuropathy in patients with diabetes mellitus].
    Mosiewicz J, Grzywa M.
    Pol Tyg Lek; 2003 Dec 23; 47(1-2):56-8. PubMed ID: 1329048
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hyperglycemia-induced alterations in synaptosomal membrane fluidity and activity of membrane bound enzymes: beneficial effect of N-acetylcysteine supplementation.
    Kamboj SS, Chopra K, Sandhir R.
    Neuroscience; 2009 Aug 18; 162(2):349-58. PubMed ID: 19426784
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.